+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Candesartan"

From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Unisia (Amlodipine + Candesartan) - API Insight, 2022 - Product Thumbnail Image

Unisia (Amlodipine + Candesartan) - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 109 Pages
  • China
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Candesartan is a drug used to treat hypertension and congestive heart failure. It is a type of angiotensin II receptor antagonist, which works by blocking the action of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve the heart's ability to pump blood. Candesartan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy. Candesartan is available in both generic and branded forms. It is marketed by several pharmaceutical companies, including Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. It is also available in combination with other drugs, such as hydrochlorothiazide and amlodipine. In the cardiovascular drugs market, Candesartan is a popular choice for treating hypertension and congestive heart failure. It is well-tolerated and has a low risk of side effects. It is also cost-effective, making it an attractive option for many patients. Companies in the Candesartan market include Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more